Pharmaceutical Supply Chains: Development of a comprehensive Digital Maturity Model for Assessment and Advancement

Abstract

As digital transformation continues to reshape entire industries, the pharmaceutical sector faces particular challenges, that are often overlooked in generic maturity models, due to its complex, highly regulated environment. In view of this gap, the aim of this research was to develop a tailor-made maturity model that pharmaceutical companies can use to assess their current digital capabilities and identify opportunities for improvement.